OXURION (EBR:OXUR) | Finanzwire

Basculer en Français

11118	Companies
244805	Keywords
172884	Articles
131993	Press releases

Home
Companies
OXURION

BRIEF

published on 09/30/2026 at 20:05, 3 days ago

Oxurion publishes its half-year results for 2026

Investors Stocks Financial Risks Oxurion 2026 Results
BRIEF

published on 09/30/2026 at 20:05, 3 days ago

Oxurion Releases Financial Update for First Half of 2026

Financial Update Software Innovation Investment Risks Clinical Research Platform Oxurion 2026 Results
PRESS RELEASE

published on 09/30/2026 at 20:00, 3 days ago

Oxurion Publishes First Half 2026 Results
Oxurion NV releases financial and business update for the six-month period ending June 30, 2026. The report is available on the company's website

Business Update Clinical Research Euronext Brussels Financial Update Oxurion NV
BRIEF

published on 09/30/2026 at 18:05, 3 days 2 hours ago

Oxurion Receives Key Transparency Notifications

Securities Transparency Goldman Sachs Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 09/30/2026 at 18:00, 3 days 2 hours ago

Oxurion Receives Transparency Notifications from Atlas Special Opportunities II LLC, The Goldman Sachs Group, Inc and Goldman Sachs International
Oxurion NV receives transparency notifications from Atlas Special Opportunities II, LLC and The Goldman Sachs Group, Inc regarding changes in shareholding percentages

Shareholding Goldman Sachs Oxurion NV Atlas Special Opportunities II Transparency Notifications
BRIEF

published on 09/30/2026 at 08:05, 3 days 12 hours ago

Oxurion in Exclusive Talks to Acquire Eclevar's Business and Assets

Acquisition Oxurion Regulatory Services Eclevar MedTech CRO
BRIEF

published on 09/30/2026 at 08:05, 3 days 12 hours ago

Oxurion in negotiations to acquire Eclevar, a MedTech specialist

Acquisition Clinical Development Oxurion Eclevar MedTech CRO
PRESS RELEASE

published on 09/30/2026 at 08:00, 3 days 12 hours ago

Oxurion enters into exclusive negotiations to acquire the business and assets of Eclevar, a MedTech-focused CRO
Oxurion NV (Euronext Brussels: OXUR) to acquire French CRO Eclevar, expanding into MedTech CRO market. Transaction details and growth potential outlined. Exclusive negotiations aim to close by 31 December 2026

Acquisition Exclusive Negotiations Oxurion NV Eclevar MedTech CRO Market
BRIEF

published on 09/23/2026 at 18:05, 10 days 2 hours ago

Oxurion Increases Voting Shares Following Bond Conversion

Voting Rights Convertible Bonds Capital Increase Atlas Special Opportunities Oxurion
PRESS RELEASE

published on 09/23/2026 at 18:00, 10 days 2 hours ago

Information on the Total Number of Voting Rights (Denominator) following Conversion Notice from Atlas
Atlas Special Opportunities, LLC converts 3 bonds in Oxurion, leading to €75,000 capital increase. Oxurion announces issuance of new shares and updated shareholder info

Shareholder Information Convertible Bonds Capital Increase Atlas Special Opportunities LLC Oxurion

Accesswire

Published on 10/03/2026 at 02:35, 18 hours 22 minutes ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 1 day 3 hours ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 1 day 7 hours ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 7 hours ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 7 hours ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/03/2026 at 15:45, 5 hours 12 minutes ago

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 21 hours 2 minutes ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 1 day ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day 1 hour ago

innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 18:00, 1 day 2 hours ago

EQS-Adhoc: AMUNDI PHYSICAL GOLD ETC (the “ETC”): Release of the first Supplemental Base Prospectus (the “Supplemental”)

Les Echos

Published on 10/02/2026 at 17:45, 1 day 3 hours ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:30, 1 day 3 hours ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/01/2026 at 19:00, 2 days 1 hour ago

AMA CORP PLC reduces its cost base while preserving XpertEye’s key functions
Published on 10/01/2026 at 18:40, 2 days 2 hours ago

Monthly disclosure of the total number of shares and voting rights - September 2026
Published on 10/01/2026 at 18:05, 2 days 2 hours ago

Covivio - Information on total number of voting rights and share capital

View all LES ECHOS COMFI WIRE